Accueil > Fr > Rech & Devpt > Publications > 2015

2015

Articles :

  • Cyclotron production of high purity 44m,44Sc with deuterons from 44CaCO3 targets Alliot C, Kerdjoudj R, Michel N, Haddad F, Huclier-Markai S. (2015) . Nucl Med Biol. 42 : 524-529.
  • Is there an interest to use deuteron beams to produce non-conventional radionuclides ? Alliot C, Audouin N, Barbet J, Bonraisin AC, Bossé V, Bourdeau C, Bourgeois M, Duchemin C, Guertin A, Haddad F, Huclier-Markai S, Kerdjoudj R, Laizé J, Métivier V, Michel N, Mokili M, Pageau M, Vidal A (2015) Frontiers in medicine, 2 : 31.
  • Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients. Bodet-Milin C, Ferrer L, Rauscher A, Masson D, Rbah-Vidal L, Faivre-Chauvet A, Cerato E, Rousseau C, Hureaux J, Couturier O, Salaün PY, Goldenberg DM, Sharkey RM, Kraeber-Bodéré F, Barbet J (2015) Front Med (Lausanne), 2 : 84.
  • Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging. Colombié M, Gouard S, Frindel M, Vidal A, Chérel M, Kraeber-Bodéré F, Rousseau C, Bourgeois M (2015) Front Med (Lausanne). 2 : 58.
  • Production of scandium-44m and scandium-44g with deuterons on calcium-44 : cross section measurements and production yield calculations. Duchemin C, Guertin A, Haddad F, Michel N, Metivier V (2015) Phys Med Biol, 60 : 6847-6864.
  • Cross section measurements of deuteron induced nuclear reactions on natural titanium up to 34 MeV. Duchemin C, Guertin A, Haddad F, Michel N, Metivier V (2015) Applied Radiat Isot, 103 : 160-165.
  • Production of medical isotopes from a thorium target irradiated by light charged particles up to 70 MeV. Duchemin C, Guertin A, Haddad F, Michel N, Métivier V (2015) Phys Med Biol. 60 : 931-946.
  • Cross section measurements of deuteron induced nuclear reactions on natural tungsten up to 34 MeV. Duchemin C, Guertin A, Haddad F, Michel N, Métivier V. (2015) Appl Radiat Isot. 97 : 52-58.
  • Single-Dose Anti-CD138 Radioimmunotherapy : Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model. Fichou N, Gouard S, Maurel C, Barbet J, Ferrer L, Morgenstern A, Bruchertseifer F, Faivre-Chauvet A, Bigot-Corbel E, Davodeau F, Gaschet J, Chérel M (2015) Front Med (Lausanne), 2 : 76.
  • Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy ? Guérard F, Barbet J, Chatal JF, Kraeber-Bodéré F, Chérel M, Haddad F. (2015) Q J Nucl Med Mol Imaging. 59 : 161-167. (IRON et ArronaxPlus)
  • A comparative thermodynamic study of the formation of scandium complexes with DTPA and DOTA, Huclier-Markai S, Alliot C, Sebti J, Brunel B, Aupiais J (2015) RSC Avances, 5 : 99606-99617. (IRON, pas ArronaxPlus)
  • A pretargeting system for tumor PET imaging and radioimmunotherapy Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Frampas E, Faivre-Chauvet A, Rauscher A, Sharkey RM, Goldenberg DM, Chatal JF, Barbet J. (2015) Front Pharmacol. 6 : 54.
  • Radioimmunotherapy : from current clinical success to future industrial breakthrough ? Kraeber-Bodéré F, Barbet J, Chatal JF (2015) J Nucl Med. 2015 Oct 29.
  • New beam monitoring tool for radiobiology experiments at the cyclotron ARRONAX. Schwob L, Koumeir C, Servagent N, Chérel M, Guertin A, Haddad F, Metivier V, Michel N, Poirier F, Rahmani A (2015) Radiat Prot Dosimetry, 166 : 257-260.
  • Radiolytic corrosion of uranium dioxide induced by He2+ localized irradiation of water : Role of the produced H2O2 distance. Traboulsi A, Vandenborre J, Blain G, Humbert B, Haddad F, Fattahi M (2015) J Nucl Mat, 467 : 832-839.